QiC Diabetes 2018 categories

Supporting the NHS RightCare Pathway: Diabetes developed in collaboration with the National Clinical Director for Diabetes and Obesity, Johnathan Valabhji, Associate National Clinical Director for Diabetes, Partha Kar, the NHS Diabetes Prevention Programme, Public Health England, Diabetes UK and a range of other stakeholders.

In addition to the entry and nomination categories there will two additional awards:

  • The Judges Special Award (not enterable directly): this award will be judged from all entries received (irrespective of category) for a project that the judges feel deserves national recognition and a platform to be shared with the wider diabetes community.
  • The NHS England Outstanding Contribution for Services in Diabetes Award (not enterable directly)

QiC Diabetes 2018 Nomination categories

Nominate your colleagues for a QiC Diabetes 2018 award

Nomination Categories Extended closing date Friday 27 July


This award recognises diabetes healthcare professionals based in the UK or Ireland who have succeeded in raising standards of care over and above their day to day role.

The nominee's information will be posted online for the public vote within a specific time frame. The top five nominations from the public vote will then be reviewed by an independent judging panel made up of senior judges and chairs who will make the final decision on who receives the award. You may not nominate yourself

The judges will be looking for evidence of changes in practice in 2017, initiated and led by the nominee, demonstrating positive outcomes in care and clear benefits for diabetes service users and/or their families and carers.

Read about 2017 Winners

Nomination terms and conditions (must be accepted to continue to nominate)

  • Nominees must be based in the UK or Ireland
  • Any organisation associated with the nominee must be on the public register
  • Nominees put forward must have no conflict of interest with any of the organisations that partner and/or support QiC Diabetes. The judging panel reserve the right to remove nominations that are considered to be a conflict of interest with the partner and/or supporter of QiC Diabetes
  • Nominators warrant that the information provided in their nominations is true, accurate and complete to the best of their knowledge
  • If at any time any information provided by a nominator is found to be false/misleading/incorrect in any manner, then all nomination and/or entries from that nominator will be excluded and the nominee will not be permitted to continue participation in the awards. The QiC Diabetes awards management may require proof of information, and/or may audit the information, contained in an nomination and/or entry
  • If clarification or verification of information is required, the QiC Diabetes awards management will make reasonable efforts to contact the nominator but will not be responsible if the nominator does not respond, does not agree to the conduct of the verification, or is uncontactable
  • In the event that it is not possible to conduct a verification of the nomination because of failure by the nominator to cooperate with a request, or for any other reason beyond the QiC Diabetes awards management’s reasonable control, the QiC Diabetes awards management may, at its discretion, disqualify the entry or continue in such other manner as it deems appropriate.

QiC Diabetes Healthcare Professional of the Year is open to all registered healthcare professionals working in diabetes.

How to nominate?

Please complete the online form below. Questions marked with a * are mandatory.

For further information or help with your submission, please contact Siobhan Thwaites on 01372 414203 or email at SThwaites@pmlive.com

Your details


Please enter a valid email address

Please enter a valid telephone number

Your nomination


Nominees must have initiated and led changes in practice in 2017

Please provide evidence of positive patient benefits and outcomes

Please provide a link to any websites, blogs etc that you think support your nomination

Fields market with a (*) are required.

If you experience any difficulties with the process, or have any questions regarding QiC Diabetes, please email SThwaites@pmlive.com, or call +44 (0)1372 414203.

Supported by the Primary Care Diabetes Society (PCDS) this award will be presented to an individual who is based in the UK or Ireland, delivers excellence in education, in a specialist or community setting: whether through developing innovative teaching tools or courses; providing mentorship for other educators; or delivering and promoting externally developed training. He or she will have a clear patient focus and be seen as a champion for education in his or her area.

Nominations are welcome for anyone working in a professional field in a specialist or community setting, where diabetes education is a major focus of the role. You may not nominate yourself

The nominee's information will be posted online for the public vote within a specific time frame. The top five nominations from the public vote will then be reviewed by an independent judging panel made up of senior judges and chairs who will make the final decision on who receives the award.

The judges will be looking for evidence of innovative and successful education to support increased awareness and knowledge of diabetes for people with diabetes and/or family and carers leading to empowerment and successful self-management, improved diabetes control and improved quality of life.

Read about 2017 Winners

Nomination terms and conditions (must be accepted to continue to nominate)

  • Nominees must be based in the UK or Ireland
  • Any organisation associated with the nominee must be on the public register
  • Nominees put forward must have no conflict of interest with any of the organisations that partner and/or support QiC Diabetes. The judging panel reserve the right to remove nominations that are considered to be a conflict of interest with the partner and/or supporter of QiC Diabetes
  • Nominators warrant that the information provided in their nominations is true, accurate and complete to the best of their knowledge
  • If at any time any information provided by a nominator is found to be false/misleading/incorrect in any manner, then all nomination and/or entries from that nominator will be excluded and the nominee will not be permitted to continue participation in the awards. The QiC Diabetes awards management may require proof of information, and/or may audit the information, contained in an nomination and/or entry
  • If clarification or verification of information is required, the QiC Diabetes awards management will make reasonable efforts to contact the nominator but will not be responsible if the nominator does not respond, does not agree to the conduct of the verification, or is uncontactable
  • In the event that it is not possible to conduct a verification of the nomination because of failure by the nominator to cooperate with a request, or for any other reason beyond the QiC Diabetes awards management’s reasonable control, the QiC Diabetes awards management may, at its discretion, disqualify the entry or continue in such other manner as it deems appropriate.

How to nominate a person for Outstanding Educator in Diabetes?

Please complete the online form below. Questions marked with a * are mandatory.

For further information or help with your submission, please contact Siobhan Thwaites on 01372 414243 or email at SThwaites@pmlive.com

Your details


Please enter a valid email address

Your nomination


Please provide evidence of education initiatives in the diabetes community

You should include evidence of achievements and results of these education initiatives in the diabetes community

Please provide a link to any websites, blogs etc that you think support your nomination

Fields market with a (*) are required.

If you experience any difficulties with the process, or have any questions regarding QiC Diabetes, please email SThwaites@pmlive.com or call +44 (0)1372 414243.

Nominate your 2018 diabetes hero! This is a special award, supported by Diabetes UK, which recognises someone very special who has supported/cared for people with diabetes in 2017.

This award will be presented to someone who is based in the UK or Ireland and is not a healthcare professional. Instead it will go to an individual such as a carer, volunteer, a person with diabetes, diabetes blogger and/or writer, family member – anyone that you think deserves this recognition. You may not nominate yourself.

Read about 2017 Winners

The nominee's information will be posted online for the public vote within a specific time frame. The top five nominations from the public vote will then be reviewed by an independent judging panel made up of senior judges and chairs who will make the final decision on who receives the award.

The judges will be looking for nominations of outstanding individuals whose care and support stands out from their peers and has made a real difference to people with diabetes.

Nomination terms and conditions (must be accepted to continue to nominate)

  • Nominees must be based in the UK or Ireland
  • Any organisation associated with the nominee must be on the public register
  • Nominees put forward must have no conflict of interest with any of the organisations that partner and/or support QiC Diabetes. The judging panel reserve the right to remove nominations that are considered to be a conflict of interest with the partner and/or supporter of QiC Diabetes
  • Nominators warrant that the information provided in their nominations is true, accurate and complete to the best of their knowledge
  • If at any time any information provided by a nominator is found to be false/misleading/incorrect in any manner, then all nomination and/or entries from that nominator will be excluded and the nominee will not be permitted to continue participation in the awards. The QiC Diabetes awards management may require proof of information, and/or may audit the information, contained in an nomination and/or entry
  • If clarification or verification of information is required, the QiC Diabetes awards management will make reasonable efforts to contact the nominator but will not be responsible if the nominator does not respond, does not agree to the conduct of the verification, or is uncontactable
  • In the event that it is not possible to conduct a verification of the nomination because of failure by the nominator to cooperate with a request, or for any other reason beyond the QiC Diabetes awards management’s reasonable control, the QiC Diabetes awards management may, at its discretion, disqualify the entry or continue in such other manner as it deems appropriate.

How to nominate a person for the People's Award?

Please complete the online form below. Questions marked with a * are mandatory.

For further information or help with your submission, please contact Siobhan Thwaites on 01372 414243 or email atSThwaites@pmlive.com

Your Details


Please enter a valid email address

Your Nomination


Please add a valid email address

Why does your nominee deserve this award?

Supporters

Materials

Fields market with a (*) are required.

The QiC Programme is organised and managed by PMGroup.

If you experience any difficulties with the process or have any questions regarding QiC Diabetes, please call +44 (0)1372 414243 or email SThwaites@pmlive.com

All other entry categories closed

Entry categories - initiatives for children, young people and emerging adults

Do you work in a type 1 specialist service team?

Have you or your team made significant positive changes to a type 1 specialist service?

This category recognises initiatives that deliver specialist support for children, young people and emerging adults with type 1 diabetes, and have demonstrated positive impact on the diagnosis and management of type 1 diabetes and associated secondary complications.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Initiatives for newly diagnosed type 1 diabetes
  • Annual care planning initiatives
  • Patient care pathway
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017
  • Best practice approaches for learning disabilities, other languages
  • Blood glucose management/monitoring initiatives
  • Psychological wellbeing services
  • Pregnancy (information, preparation)
  • Innovations in insulin therapy
  • Inpatient care
  • Emerging adult to adult service transition
  • Peer to peer support
  • Screening and management/secondary prevention of complications

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


Please note type 1 pathways should be entered into the type 1 specialist service category

Have you or your multidisciplinary team (MDT) made significant positive changes to services that are based in the community and/or in hospital?

An efficient patient care pathway is critical to empower self-management and avoid unnecessary complications. Based on patient needs and goals, the focus of the patient care pathway is to improve the quality and delivery of effective integrated services that are based in the community and/or in hospital.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Two entry sections to choose from:

A. Generic pathways

Entries to this category could include:

  • Best practice for non-specialist healthcare professional and allied health care professional led initiative for community and/or hospital settings
  • Best practice for nutritional and pharmacological management pathways
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible
  • Best practice for clinical engagement, leadership and governance to drive improvement and quality of services
  • Best practice for commissioning services supporting new models of care in an integrated framework:
    • Self-management and health literacy
    • Healthcare professional support
    • Community and hospital based integrated care
    • Addressing variation: postcode, hard-to-reach and vulnerable groups, specialist services.

B. Specialist care pathways

Entries to this category could include:

  • Best practice for reasonable adjustments for people with a learning disability who have diabetes
  • Inpatient diabetes team, shared records and advice line
  • Management services for acute diabetes emergencies in varied clinical settings such as:
    • Hospital care pathway
    • Wound care, avoidance of heel pressure sores
    • Patient safety + protecting from harm
  • Cardiovascular
  • Peripheral vascular disease
  • Preconception pregnancy planning advice
  • Paediatric diabetes
  • Vision – optometrist and ophthalmology
  • Foot care and podiatry
  • Psychological wellbeing
  • Renal and dialysis
  • Oral health.

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


What are you doing to better inform and empower children/young people/emerging adults living with type 1 or type 2 diabetes and their families/carers?

This award recognises those teams and individuals that are working to educate and empower children, young people and emerging adults  to self-manage their diabetes and stay as healthy as possible. Programmes may include structured education, other education initiatives, influencing clinical, psychological or social well-being and are welcomed from community or clinical settings. Initiatives can be at any stage from diagnosis, for different age groups and from children’s services to transitioning to adult services

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • GP practice/CCG significant improvement in attendance at structured education programmes
  • Health literacy in self-management – bridging the gap between what HCPs know and what patients and families/carers understand
  • Educational digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be elegible
  • Safety and awareness of potential complications and early warning signs
  • Personalised advice on weight management, nutrition and physical activity from appropriately trained healthcare professional as part of structured education programme
  • Mental health
  • Pharmacies working to provide safe effective pharmacological management of diabetes to include cross disease management with diabetes as primary disease
  • Foot and eye care education and services initiatives
  • Women’s health: preconception, pregnancy and contraception
  • Self management education for people with diabetes who have long term conditions requiring specialist services eg cardiovascular disease or cystic fibrosis

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


Do you work in a collaborative partnership that has improved or changed the treatment and management of diabetes for children, young people and emerging adults?

Healthcare providers, social care, patient associations, charities, non-governmental agencies and pharmaceutical companies can improve outcomes for people with diabetes, through high-quality, cost-effective treatment and management.

Collaborations across traditional sector boundaries provide opportunities to improve patient outcomes through joint working ensuring that patients get optimal care, with support to help them maximise the benefits of treatment across health and social care.

Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery. These initiatives may have operated at a local or national level.

This award will recognise outstanding collaborative projects that demonstrate working with internal and external stakeholders to achieve a common goal, ie initiatives created and implemented by multi-organisational partnership: for example, work carried out by teams comprising NHS, charities, social care etc that significantly contribute to self-management, avoidance of complications and treatment of diabetes.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Collaborative working between health, social care teams, charities and patient groups
  • Service referral and key relationships
  • Clinical collaboration:
    • Long-term care planning for multiple and complex illnesses
    • Collaboration between primary and specialist care to identify diabetes issues early and avoid long-term complications
    • Community collaboration initiatives
    • Patient safety initiatives
  • Non-traditional collaborations i.e. technology, IT and communications
  • Clinical Commissioning Group partnerships ie prevention, safety initiatives
  • Local authority/government partnerships
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 35 points from 3 subsections

For this category the judges are primarily interested in the innovation and collaborative aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

5

Background, brief overview of the initiative

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel collaborations, creative solutions to traditional barriers to collaborative working.

C

Collaboration

15

Demonstrate strong leadership and collaboration partnerships to delivers solutions supporting improved diabetes services and outcomes.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further details of how the initiative was developed

A

Project Planning

10

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed.

D

RESULTS

Max 35 points divided between 5 quality improvement areas

This section provides detail of results for the outcomes described in section 8A-8C above, along with user feedback, economic viability and potential or achieved impact

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.

5

Sustainability and evidence for sharing practice  and dissemination

10

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare settings. Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


Do you work in a team that has made an outstanding contribution to the treatment and management of diabetes in children, young people and emerging adults?

Teamwork plays a critical and growing role in high-quality diabetes care.

This award recognises the value of outstanding multidisciplinary team achievements and contributions that help better prevent, diagnose or treat diabetes and support self-care management to improve the experience and outcomes for children, young people and emerging adults with diabetes and/or their families/carers.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entrants to this category could include:

  • Multidisciplinary teams
  • Structured education teams
  • Service referral teams
  • Clinical commissioning groups
  • GP practice initiatives
  • NHS organisations
  • Community teams
  • In patient teams
  • Specialist service teams
  • Management team that has introduced significant advances in clinical practice, diabetes service user support (including links to social care), service quality or efficiency
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 35 points from 3 subsections

For this category the judges are particularly interested in the innovation and team working aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

5

Background, brief overview of your entry highlighting why your team initiative stands out

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches to multidisciplinary working, creative solutions to longstanding barriers to effective teamwork.

C

Teamwork & Collaboration

15

Describe team members, leadership and structure, along with evidence of how effective teamwork supported improved service user experience and outcomes.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further details of how the initiative was developed

A

Project Planning

10

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed.

D

RESULTS

Max 35 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.

5

Sustainability and evidence for sharing practice  and dissemination

10

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting). Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


Entry categories - initiatives for adults

Do you work in a type 1 specialist service team?

Have you or your team made significant positive changes to an adult type 1 specialist service?

This category recognises initiatives that deliver specialist support for adults with type 1 diabetes and have demonstrated positive impact on the diagnosis and management of type 1 diabetes and associated secondary complications.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Specialist services for newly diagnosed type 1 diabetes
  • Annual care planning initiatives
  • Patient care pathways
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017
  • Best practice approaches for learning disabilities, other languages
  • Blood glucose management/monitoring initiatives
  • Psychological wellbeing services eg diabetes distress, sexual dysfunction, insulin omission
  • Preconception and pregnancy
  • Innovations in insulin therapy
  • Inpatient care
  • Emerging adult to adult service transitions
  • Peer to peer support
  • Screening and management/secondary prevention of complications.

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


Please note type 1 pathways should be entered into the type 1 specialist service category

Have you or your multidisciplinary team (MDT) made significant positive changes to services that are based in the community and/or in hospital?

An efficient patient care pathway is critical to empower self-management and avoid unnecessary complications. Based on patient needs and goals, the focus of the patient care pathway is to improve the quality and delivery of effective integrated services that are based in the community and/or in hospital.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Two entry sections to choose from:

A. Generic pathways

Entries to this category could include:

  • Best practice for non-specialist healthcare professional and allied health care professional led initiative for community and/or hospital settings
  • Best practice for nutritional and pharmacological management pathways
  • Best use of digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible
  • Best practice for clinical engagement, leadership and governance to drive improvement and quality of services
  • Best practice for commissioning services supporting new models of care in an integrated framework:
    • Self-management and health literacy
    • Healthcare professional support
    • Community and hospital based integrated care
    • Addressing variation: postcode, hard-to-reach and vulnerable groups, specialist services

B. Specialist care pathways

Entries to this category could include:

  • Best practice reasonable adjustments for learning disabilities
  • Inpatient diabetes team, shared records and advice line
  • Management services for acute diabetes emergencies in varied clinical settings such as:
    • Hospital care pathway
    • Wound care, avoidance of heel pressure sores
    • Patient safety + protecting from harm
  • Cardiovascular and peripheral vascular disease
  • Preconception, pregnancy (pre-existing and gestational diabetes) and menopause
  • Vision – optometrist and ophthalmology
  • Foot care and podiatry
  • Psychological wellbeing
  • Renal disease and dialysis
  • Oral Health

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


What are you doing to better inform and empower adults living with type 1 or type 2 diabetes and their families/carers?

This award recognises those teams and individuals that are working to educate and empower adults to self-manage their diabetes to help those living with diabetes and stay as healthy as possible. Programmes may include structured education, other education initiatives, influencing clinical, psychological or social well-being and are welcomed from community or clinical settings.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • GP practice/CCG significant improvement in attendance at structured education programmes
  • Health literacy in self-management – bridging the gap between what HCPs know and what patients and families/carers understand
  • Educational digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible
  • Safety and awareness of potential complications and early warning signs
  • Personalised advice on weight management, nutrition and physical activity from appropriately trained healthcare professional as part of structured education programme
  • Psychological wellbeing
  • Pharmacies working to provide safe effective pharmacological management of diabetes to include cross disease management with diabetes as primary disease
  • Foot and eye care education and services initiatives
  • Women’s health: preconception, pregnancy, contraception and menopause
  • Self management education for people with diabetes who have long term conditions requiring specialist services eg cardiovascular disease or cystic fibrosis

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


Do you work in a collaborative partnership that has improved or changed the treatment and management of diabetes for adults?

Healthcare providers, social care, patient associations, charities, non-governmental agencies and pharmaceutical companies can improve outcomes for people with diabetes, through

high-quality, cost-effective treatment and management.

Collaborations across traditional sector boundaries provide opportunities to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment across health and social care.

Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery. These initiatives may have operated at a local or national level.

This award will recognise outstanding collaborative projects that demonstrate working with internal and external stakeholders to achieve a common goal, ie initiatives created and implemented by multi-organisational partnership: for example, work carried out by teams comprising NHS, charities social care etc. that significantly contribute to self-management, avoidance of complications and treatment of diabetes.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Collaborative working between health, social care teams, charities and patient groups
  • Service referral and key relationships
  • Clinical collaboration:
    • Long-term care planning for multiple and complex illnesses
    • Collaboration between primary and specialist care to identify diabetes issues early and avoid long-term complications
    • Community collaboration initiatives
    • Patient safety initiatives
  • Non-traditional collaborations eg technology, IT and communications
  • Clinical Commissioning Group partnerships eg prevention, safety initiatives
  • Local authority/government partnerships
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible

Scoring criteria, judges will be looking for evidence of:


Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 35 points from 3 subsections

For this category the judges are primarily interested in the innovation and collaborative aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

5

Background, brief overview of the initiative

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel collaborations, creative solutions to traditional barriers to collaborative working.

C

Collaboration

15

Demonstrate strong leadership and collaboration partnerships to delivers solutions supporting improved diabetes services and outcomes.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further details of how the initiative was developed

A

Project Planning

10

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed.

D

RESULTS

Max 35 points divided between 5 quality improvement areas

This section provides detail of results for the outcomes described in section 8A-8C above, along with user feedback, economic viability and potential or achieved impact

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.

5

Sustainability and evidence for sharing practice  and dissemination

10

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.


Achieved spread of initiative to wider geographical areas or other healthcare settings. Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


Do you work in a team that has made an outstanding contribution to the treatment and management of diabetes in adults?

Teamwork plays a critical and growing role in high-quality diabetes care.

This award recognises the value of outstanding multidisciplinary team achievements and contributions that help better prevent, diagnose or treat diabetes and support self-care management to improve the experience and outcomes for adults with diabetes and/or their families/carers.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entrants to this category could include:

  • Multidisciplinary teams
  • Structured education teams
  • Service referral teams
  • Clinical commissioning groups
  • GP practice initiatives
  • NHS organisations
  • Community teams
  • In patient teams
  • Specialist service teams
  • Management team that has introduced significant advances in clinical practice, diabetes service user support (including links to social care), service quality or efficiency
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 35 points from 3 subsections

For this category the judges are particularly interested in the innovation and team working aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

5

Background, brief overview of your entry highlighting why your team initiative stands out

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches to multidisciplinary working, creative solutions to longstanding barriers to effective teamwork.

C

Teamwork & Collaboration

15

Describe team members, leadership and structure, along with evidence of how effective teamwork supported improved service user experience and outcomes.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further details of how the initiative was developed

A

Project Planning

10

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed.

D

RESULTS

Max 35 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.

5

Sustainability and evidence for sharing practice  and dissemination

10

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting). Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


Entry categories - open to all

Do you work in prevention and early diagnosis of type 2 diabetes and/or its associated complications in the under 25s age or adult category?

This category recognises the impact of preventative initiatives to help people and their families and/or carers to live healthier lives and reduce the risk of developing type 2 or gestational diabetes, and of early diagnosis, and diabetes management initiatives to optimise outcomes and reduce complications.

Entries may be submitted by NHS organisations, charities, national bodies, CCGs, local authorities, schools, pharmacies and private/consumer brand initiatives operating at a locality, regional or national level.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Diabetes awareness and promotion of healthy diet and lifestyle for the general population and for specific at risk groups, such as those with a family history of type 2 diabetes, previous gestational diabetes, people from more socially deprived areas and the BAME community.
  • Life-threatening disease avoidance through initiatives which impact and lower risk of developing diabetes eg cardiovascular health, obesity interventions
  • Initiatives addressing health literacy
  • Increasing screening uptake or improving screening eg diagnosing diabetes. in optometrist practices, pharmacies, A&E, company health check initiatives
  • Use of diagnostic tools
  • Digital and technology initiatives to aid prevention, diagnosis or management of type 2 diabetes and/or associated complications: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017
  • Local/regional/national initiatives aimed at improving care and outcomes for people diagnosed with type 2 or gestational diabetes eg:
    • Psychological wellbeing initiatives addressing.mood/depression, sexual dysfunction, disordered eating
    • Dietary or weight management initiatives for those diagnosed with T2DM or GDM
    • Annual care planning initiatives
    • Patient safety modules
    • Adapting best practice approaches for particular needs eg learning disabilities, other languages
    • Blood glucose management/monitoring initiatives
    • Innovations in prescribable diabetes therapies
  • Innovative practice models supporting accurate and timely diagnosis or improving management and outcomes of complications relating to type 2 and gestational diabetes eg
    • Short-term: hypoglycaemia, hyperosmolar hyperglycaemic state (HHS)
    • Long term: cardiovascular disease, ophthalmic complications, renal disease, autonomic or peripheral neuropathies, adverse pregnancy outcomes

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section scores

Guidance on content

Section 7

Main Outcomes

Max 20 points from 2 subsections

For this category the judges are particularly interested in the innovative aspects of your initiative. This is highlighted in the first section of the submission statement

A

Summary

5

Background, brief overview of the initiative.

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.

Section 8

Planning & Methods

Max 40  points from 3 subsections

This section provides further details of how the initiative was developed

A

Project planning

15

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

15

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Total of 40 points divided between 5 quality improvement areas

This section provides details of results for outcomes outlined in Section 8A-8C, along with user feedback, economic viability, potential or achieved impact, dissemination and sustainability.

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget

5

Sustainability and evidence for sharing practice  and dissemination

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken


Have you previously been recognised within Quality in Care Diabetes?

Have you consistently sustained the service commissioning for your initiative for a minimum of 2 years?

This award recognises people and teams who have been recognised within Quality in Care Diabetes.

They will have successfully disseminated and sustained their best practice for a minimum period of two years for the ultimate benefit of people with diabetes and/or their families and carers

If you have previously been recognised at the QiC award (winners, highly commended, commended, finalist) please complete entry form and attach your original award winning entry and supplementary materials for this initiative.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 40 points from 3 subsections

For this category the judges are particularly interested in the dissemination and sustainability aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

10

Background, brief overview of the initiative highlighting the key sustainability and dissemination aspects.

B

Evidence for sharing practice and dissemination

15

Achieved spread of initiative to wider geographical areas or other healthcare setting)Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken

C

Sustainability

15

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further detail of how the initiative was developed. For previous entries content should focus on developments since the initiative was last entered into QiC diabetes.

A

Project Planning

10

Describe the identified need & opportunity for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed

D

RESULTS

Max 30 points from 4 quality improvement areas

This section provides detail of results for the outcomes described in section 8A-8C above, along with user feedback, economic viability and potential or achieved impact

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used...

4

Cost efficiency and economic viability

10

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget


Is your work eligible for entry?

Please attach and clearly mark any previous QiC Diabetes entries relating to the same initiative. Include the category it was entered into, placing (if applicable) and the feedback you received. . Your entry will need to demonstrate that you have addressed the judges’ comments or how the initiative has progressed, so make sure your entry form reflects this.

Programmes and initiatives should relate to the period January 2012 to December 2017 and be from throughout the UK and Ireland.

Organisations, companies or individuals may submit entries on behalf of themselves or others and may enter the same project in a maximum of one category. Organisations can enter separate projects in multiple categories.

Particular credit will be given to projects which demonstrate results having quality and/or efficiency benefits which could be replicated elsewhere, thereby having a greater impact than their initial focus.


  • KEY DATES
  • Launch at Diabetes UK Professional Conference 2018:
    14 March
  • Nomination Categories Extended closing date Friday 27 July
  • Judging day: 19 July
  • Awards ceremony: 18 October
QiC Diabetes is partnered by:
Supported by: